Skin Stem Cell Niches
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Development and Maintenance of Epidermal Stem Cells in Skin Adnexa
International Journal of Molecular Sciences Review Development and Maintenance of Epidermal Stem Cells in Skin Adnexa Jaroslav Mokry * and Rishikaysh Pisal Medical Faculty, Charles University, 500 03 Hradec Kralove, Czech Republic; [email protected] * Correspondence: [email protected] Received: 30 October 2020; Accepted: 18 December 2020; Published: 20 December 2020 Abstract: The skin surface is modified by numerous appendages. These structures arise from epithelial stem cells (SCs) through the induction of epidermal placodes as a result of local signalling interplay with mesenchymal cells based on the Wnt–(Dkk4)–Eda–Shh cascade. Slight modifications of the cascade, with the participation of antagonistic signalling, decide whether multipotent epidermal SCs develop in interfollicular epidermis, scales, hair/feather follicles, nails or skin glands. This review describes the roles of epidermal SCs in the development of skin adnexa and interfollicular epidermis, as well as their maintenance. Each skin structure arises from distinct pools of epidermal SCs that are harboured in specific but different niches that control SC behaviour. Such relationships explain differences in marker and gene expression patterns between particular SC subsets. The activity of well-compartmentalized epidermal SCs is orchestrated with that of other skin cells not only along the hair cycle but also in the course of skin regeneration following injury. This review highlights several membrane markers, cytoplasmic proteins and transcription factors associated with epidermal SCs. Keywords: stem cell; epidermal placode; skin adnexa; signalling; hair pigmentation; markers; keratins 1. Epidermal Stem Cells as Units of Development 1.1. Development of the Epidermis and Placode Formation The embryonic skin at very early stages of development is covered by a surface ectoderm that is a precursor to the epidermis and its multiple derivatives. -
Mir-338-3P Is Regulated by Estrogens Through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (Cafs)
cells Article miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) Adele Vivacqua 1,*, Anna Sebastiani 1, Anna Maria Miglietta 2, Damiano Cosimo Rigiracciolo 1, Francesca Cirillo 1, Giulia Raffaella Galli 1, Marianna Talia 1, Maria Francesca Santolla 1, Rosamaria Lappano 1, Francesca Giordano 1, Maria Luisa Panno 1 and Marcello Maggiolini 1,* 1 Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy; [email protected] (A.S.); [email protected] (D.C.R.); [email protected] (F.C.); [email protected] (G.R.G.); [email protected] (M.T.); [email protected] (M.F.S.); [email protected] (R.L.); [email protected] (F.G.); [email protected] (M.L.P.) 2 Regional HospitalCosenza, 87100 Cosenza, Italy; [email protected] * Correspondence: [email protected] (A.V.); [email protected] (M.M.); Tel.: +39-0984-493-048 (A.V.); +39-0984-493-076 (M.M.) Received: 12 October 2018; Accepted: 7 November 2018; Published: 9 November 2018 Abstract: Estrogens acting through the classic estrogen receptors (ERs) and the G protein estrogen receptor (GPER) regulate the expression of diverse miRNAs, small sequences of non-coding RNA involved in several pathophysiological conditions, including breast cancer. In order to provide novel insights on miRNAs regulation by estrogens in breast tumor, we evaluated the expression of 754 miRNAs by TaqMan Array in ER-negative and GPER-positive SkBr3 breast cancer cells and cancer-associated fibroblasts (CAFs) upon 17β-estradiol (E2) treatment. Various miRNAs were regulated by E2 in a peculiar manner in SkBr3 cancer cells and CAFs, while miR-338-3p displayed a similar regulation in both cell types. -
Expression in 3T3-L1 Adipocytes (Obesity/Nuclear Receptor/Peroxisome Proliferator-Activated Receptor Y) CALEB B
Proc. Natl. Acad. Sci. USA Vol. 93, pp. 5793-5796, June 1996 Cell Biology Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes (obesity/nuclear receptor/peroxisome proliferator-activated receptor y) CALEB B. KALLEN AND MITCHELL A. LAZAR Division of Endocrinology, Diabetes, and Metabolism, Departments of Medicine and Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 Communicated by M. Daniel Lane, Johns Hopkins University School of Medicine, Baltimore, MD, February 20, 1996 (receivedfor review January 11, 1996) ABSTRACT Lack of leptin (ob) protein causes obesity in We hypothesized that thiazolidinediones, which regulate the mice. The leptin gene product is important for normal regu- expression of adipocyte-specific genes via PPARy (14), might lation of appetite and metabolic rate and is produced exclu- also play a role in the regulation of leptin gene expression. We sively by adipocytes. Leptin mRNA was induced during the found that several thiazolidinediones dramatically repressed adipose conversion of 3T3-L1 cells, which are useful for leptin gene expression in differentiated 3T3-L1 adipocytes. studying adipocyte differentiation and function under con- The ED50 for inhibition of leptin expression by the thiazo- trolled conditions. We studied leptin regulation by antidia- lidinedione BRL49653 was similar to its ED50 for inducing betic thiazolidinedione compounds, which are ligands for the adipocyte differentiation and to its reported Kd for binding to adipocyte-specific nuclear receptor peroxisome proliferator- PPARy. Thus, antidiabetic thiazolidinediones down-regulate activated receptor y (PPARy) that regulates the transcription leptin expression in 3T3-L1 adipocytes by a mechanism that of other adipocyte-specific genes. Remarkably, leptin gene may involve PPARy. -
ACTH Enhances Lipid Accumulation in Bone-Marrow Derived Mesenchymal Stem Cells Undergoing Adipogenesis" (2015)
Molloy College DigitalCommons@Molloy Faculty Works: Biology, Chemistry, and Biology, Chemistry, and Environmental Science Environmental Studies 2015 ACTH Enhances Lipid Accumulation in Bone- marrow derived Mesenchymal stem cells undergoing adipogenesis Jodi F. Evans Ph.D. Molloy College, [email protected] Thomas Rhodes Michelle Pazienza Follow this and additional works at: https://digitalcommons.molloy.edu/bces_fac Part of the Biology Commons, and the Chemistry Commons DigitalCommons@Molloy Feedback Recommended Citation Evans, Jodi F. Ph.D.; Rhodes, Thomas; and Pazienza, Michelle, "ACTH Enhances Lipid Accumulation in Bone-marrow derived Mesenchymal stem cells undergoing adipogenesis" (2015). Faculty Works: Biology, Chemistry, and Environmental Studies. 11. https://digitalcommons.molloy.edu/bces_fac/11 This Peer-Reviewed Article is brought to you for free and open access by the Biology, Chemistry, and Environmental Science at DigitalCommons@Molloy. It has been accepted for inclusion in Faculty Works: Biology, Chemistry, and Environmental Studies by an authorized administrator of DigitalCommons@Molloy. For more information, please contact [email protected],[email protected]. Journal of Student Research (2015) Volume 4, Issue 1: pp. 69-73 Research Article ACTH Enhances Lipid Accumulation in Bone-marrow derived Mesenchymal stem cells undergoing adipogenesis Thomas Rhodesa, Michelle Pazienzaa and Jodi F. Evansa ACTH is a major hormone of the stress axis or hypothalamic-pituitary-adrenal (HPA) axis. It is derived from pro- opiomelanocortin (POMC) the precursor to the melanocortin family of peptides. POMC produces the biologically active melanocortin peptides via a series of enzymatic steps in a tissue-specific manner, yielding the melanocyte-stimulating hormones (MSHs), corticotrophin (ACTH) and β-endorphin. The melanocortin system plays an imperative role in energy expenditure, insulin release and insulin sensitivity. -
Profiling G Protein-Coupled Receptors of Fasciola Hepatica Identifies Orphan Rhodopsins Unique to Phylum Platyhelminthes
bioRxiv preprint doi: https://doi.org/10.1101/207316; this version posted October 23, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Profiling G protein-coupled receptors of Fasciola hepatica 2 identifies orphan rhodopsins unique to phylum 3 Platyhelminthes 4 5 Short title: Profiling G protein-coupled receptors (GPCRs) in Fasciola hepatica 6 7 Paul McVeigh1*, Erin McCammick1, Paul McCusker1, Duncan Wells1, Jane 8 Hodgkinson2, Steve Paterson3, Angela Mousley1, Nikki J. Marks1, Aaron G. Maule1 9 10 11 1Parasitology & Pathogen Biology, The Institute for Global Food Security, School of 12 Biological Sciences, Queen’s University Belfast, Medical Biology Centre, 97 Lisburn 13 Road, Belfast, BT9 7BL, UK 14 15 2 Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 16 17 3 Institute of Integrative Biology, University of Liverpool, Liverpool, UK 18 19 * Corresponding author 20 Email: [email protected] 21 1 bioRxiv preprint doi: https://doi.org/10.1101/207316; this version posted October 23, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 22 Abstract 23 G protein-coupled receptors (GPCRs) are established drug targets. Despite their 24 considerable appeal as targets for next-generation anthelmintics, poor understanding 25 of their diversity and function in parasitic helminths has thwarted progress towards 26 GPCR-targeted anti-parasite drugs. -
Corrective Gene Transfer of Keratinocytes from Patients with Junctional Epidermolysis Bullosa Restores Assembly of Hemidesmosomes in Reconstructed Epithelia
Gene Therapy (1998) 5, 1322–1332 1998 Stockton Press All rights reserved 0969-7128/98 $12.00 http://www.stockton-press.co.uk/gt Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia J Vailly1, L Gagnoux-Palacios1, E Dell’Ambra2, C Rome´ro1, M Pinola3, G Zambruno3, M De Luca2,3 J-P Ortonne1,4 and G Meneguzzi1 1U385 INSERM, Faculte´ de Me´decine, Nice; 4Service de Dermatologie, Hoˆpital L’Archet, Nice, France; Laboratories of 2Tissue Engineering and 3Molecular and Cell Biology, Istituto Dermopatico dell’Immacolata, Rome, Italy Herlitz junctional epidermolysis bullosa (H-JEB) provides deposited into the extracellular matrix. Re-expression of a promising model for somatic gene therapy of heritable laminin-5 induced cell spreading, nucleation of hemides- mechano-bullous disorders. This genodermatosis is mosomal-like structures and enhanced adhesion to the cul- caused by the lack of laminin-5 that results in absence of ture substrate. Organotypic cultures performed with the hemidesmosomes (HD) and defective adhesion of squam- transduced keratinocytes, reconstituted epidermis closely ous epithelia. To establish whether re-expression of lami- adhering to the mesenchyme and presenting mature hemi- nin-5 can restore assembly of the dermal-epidermal attach- desmosomes, bridging the cytoplasmic intermediate fila- ment structures lacking in the H-JEB skin, we corrected the ments of the basal cells to the anchoring filaments of the genetic mutation hindering expression of the 3 chain of basement membrane. Our results provide the first evi- laminin-5 in human H-JEB keratinocytes by transfer of a dence of phenotypic reversion of JEB keratinocytes by laminin 3 transgene. -
The Mechanism of White and Brown Adipocyte Differentiation
Review Obesity and Metabolic Syndrome Diabetes Metab J 2013;37:85-90 http://dx.doi.org/10.4093/dmj.2013.37.2.85 pISSN 2233-6079 · eISSN 2233-6087 DIABETES & METABOLISM JOURNAL The Mechanism of White and Brown Adipocyte Differentiation Hironori Nakagami Division of Vascular Medicine and Epigenetics, Osaka University United Graduate School of Child Development, Osaka, Japan Obesity gives vent to many diseases such as type 2 diabetes, hypertension, and hyperlipidemia, being considered as the main causes of mortality and morbidity worldwide. The pathogenesis and pathophysiology of metabolic syndrome can well be under- stood by studying the molecular mechanisms that control the development and function of adipose tissue. In human body, exist two types of adipose tissue, the white and the brown one, which are reported to play various roles in energy homeostasis. The major and most efficient storage of energy occurs in the form of triglycerides in white adipose tissue while brown adipose tissue actively participates in both basal and inducible energy consumption in the form of thermogenesis. Recent years have observed a rapid and greater interest towards developmental plasticity and therapeutic potential of stromal cells those isolated from adipose tissue. The adipocyte differentiation involves a couple of regulators in the white or brown adipogenesis. Peroxisome prolifera- tors-activated receptor-γ actively participates in regulating carbohydrate and lipid metabolism, and also acts as main regulator of both white and brown adipogenesis. This review based on our recent research, seeks to highlight the adipocyte differentiation. Keywords: Adipogenesis; Adipose tissue, brown; Genes, homeobox; miR-196a; Obesity INTRODUCTION cells (MSCs) which differentiate into multiple lineages such as adipocytes in vitro, providing a unique platform to study mo- Obesity has emerged as one of the deadliest life threat of the lecular machineries of adipocyte differentiation. -
Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
Article Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma Graphical Abstract Authors Scott X. Atwood, Kavita Y. Sarin, ..., Anthony E. Oro, Jean Y. Tang Correspondence [email protected] (A.E.O.), [email protected] (J.Y.T.) In Brief Atwood et al. identify key SMO mutations that confer resistance to SMO inhibitors in basal cell carcinomas (BCC) and show that these mutants respond to aPKC-i/l or GLI2 inhibitors, providing potential approaches for treating BCCs resistant to SMO inhibitors. Highlights Accession Numbers d Functional SMO mutations are detected in the majority of GSE58377 SMO inhibitor-resistant BCCs d Resistance occurs by suppressing drug responsiveness and SMO autoinhibition d SMO mutants explain both intrinsic and acquired tumor resistance d Inhibition of aPKC-i/l or GLI2 bypasses SMO variants to suppress Hedgehog signaling Atwood et al., 2015, Cancer Cell 27, 342–353 March 9, 2015 ª2015 Elsevier Inc. http://dx.doi.org/10.1016/j.ccell.2015.02.002 Cancer Cell Article Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma Scott X. Atwood,1,2 Kavita Y. Sarin,1,2 Ramon J. Whitson,1 Jiang R. Li,1 Geurim Kim,1 Melika Rezaee,1 Mina S. Ally,1 Jinah Kim,1 Catherine Yao,1 Anne Lynn S. Chang,1,3 Anthony E. Oro,1,3,* and Jean Y. Tang1,3,* 1Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA 2Co-first author 3Co-senior author *Correspondence: [email protected] (A.E.O.), [email protected] (J.Y.T.) http://dx.doi.org/10.1016/j.ccell.2015.02.002 SUMMARY Advanced basal cell carcinomas (BCCs) frequently acquire resistance to Smoothened (SMO) inhibitors through unknown mechanisms. -
System, Method and Software for Calculation of a Cannabis Drug Efficiency Index for the Reduction of Inflammation
International Journal of Molecular Sciences Article System, Method and Software for Calculation of a Cannabis Drug Efficiency Index for the Reduction of Inflammation Nicolas Borisov 1,† , Yaroslav Ilnytskyy 2,3,†, Boseon Byeon 2,3,4,†, Olga Kovalchuk 2,3 and Igor Kovalchuk 2,3,* 1 Moscow Institute of Physics and Technology, 9 Institutsky lane, Dolgoprudny, Moscow Region 141701, Russia; [email protected] 2 Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada; [email protected] (Y.I.); [email protected] (B.B.); [email protected] (O.K.) 3 Pathway Rx., 16 Sandstone Rd. S., Lethbridge, AB T1K 7X8, Canada 4 Biomedical and Health Informatics, Computer Science Department, State University of New York, 2 S Clinton St, Syracuse, NY 13202, USA * Correspondence: [email protected] † First three authors contributed equally to this research. Abstract: There are many varieties of Cannabis sativa that differ from each other by composition of cannabinoids, terpenes and other molecules. The medicinal properties of these cultivars are often very different, with some being more efficient than others. This report describes the development of a method and software for the analysis of the efficiency of various cannabis extracts to detect the anti-inflammatory properties of the various cannabis extracts. The method uses high-throughput gene expression profiling data but can potentially use other omics data as well. According to the signaling pathway topology, the gene expression profiles are convoluted into the signaling pathway activities using a signaling pathway impact analysis (SPIA) method. The method was tested by inducing inflammation in human 3D epithelial tissues, including intestine, oral and skin, and then exposing these tissues to various extracts and then performing transcriptome analysis. -
Tamoxifen Resistance: Emerging Molecular Targets
International Journal of Molecular Sciences Review Tamoxifen Resistance: Emerging Molecular Targets Milena Rondón-Lagos 1,*,†, Victoria E. Villegas 2,3,*,†, Nelson Rangel 1,2,3, Magda Carolina Sánchez 2 and Peter G. Zaphiropoulos 4 1 Department of Medical Sciences, University of Turin, Turin 10126, Italy; [email protected] 2 Faculty of Natural Sciences and Mathematics, Universidad del Rosario, Bogotá 11001000, Colombia; [email protected] 3 Doctoral Program in Biomedical Sciences, Universidad del Rosario, Bogotá 11001000, Colombia 4 Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge 14183, Sweden; [email protected] * Correspondence: [email protected] (M.R.-L.); [email protected] (V.E.V.); Tel.: +39-01-1633-4127 (ext. 4388) (M.R.-L.); +57-1-297-0200 (ext. 4029) (V.E.V.); Fax: +39-01-1663-5267 (M.R.-L.); +57-1-297-0200 (V.E.V.) † These authors contributed equally to this work. Academic Editor: William Chi-shing Cho Received: 5 July 2016; Accepted: 16 August 2016; Published: 19 August 2016 Abstract: 17β-Estradiol (E2) plays a pivotal role in the development and progression of breast cancer. As a result, blockade of the E2 signal through either tamoxifen (TAM) or aromatase inhibitors is an important therapeutic strategy to treat or prevent estrogen receptor (ER) positive breast cancer. However, resistance to TAM is the major obstacle in endocrine therapy. This resistance occurs either de novo or is acquired after an initial beneficial response. The underlying mechanisms for TAM resistance are probably multifactorial and remain largely unknown. Considering that breast cancer is a very heterogeneous disease and patients respond differently to treatment, the molecular analysis of TAM’s biological activity could provide the necessary framework to understand the complex effects of this drug in target cells. -
Contribution of Adipogenesis to Healthy Adipose Tissue Expansion in Obesity
Contribution of adipogenesis to healthy adipose tissue expansion in obesity Lavanya Vishvanath, Rana K. Gupta J Clin Invest. 2019;129(10):4022-4031. https://doi.org/10.1172/JCI129191. Review Series The manner in which white adipose tissue (WAT) expands and remodels directly impacts the risk of developing metabolic syndrome in obesity. Preferential accumulation of visceral WAT is associated with increased risk for insulin resistance, whereas subcutaneous WAT expansion is protective. Moreover, pathologic WAT remodeling, typically characterized by adipocyte hypertrophy, chronic inflammation, and fibrosis, is associated with insulin resistance. Healthy WAT expansion, observed in the “metabolically healthy” obese, is generally associated with the presence of smaller and more numerous adipocytes, along with lower degrees of inflammation and fibrosis. Here, we highlight recent human and rodent studies that support the notion that the ability to recruit new fat cells through adipogenesis is a critical determinant of healthy adipose tissue distribution and remodeling in obesity. Furthermore, we discuss recent advances in our understanding of the identity of tissue-resident progenitor populations in WAT made possible through single-cell RNA sequencing analysis. A better understanding of adipose stem cell biology and adipogenesis may lead to novel strategies to uncouple obesity from metabolic disease. Find the latest version: https://jci.me/129191/pdf REVIEW SERIES: MECHANISMS UNDERLYING THE METABOLIC SYNDROME The Journal of Clinical Investigation Series Editor: Philipp E. Scherer Contribution of adipogenesis to healthy adipose tissue expansion in obesity Lavanya Vishvanath and Rana K. Gupta Touchstone Diabetes Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. The manner in which white adipose tissue (WAT) expands and remodels directly impacts the risk of developing metabolic syndrome in obesity. -
Emerging Role of Tumor Cell Plasticity in Modifying Therapeutic Response
Signal Transduction and Targeted Therapy www.nature.com/sigtrans REVIEW ARTICLE OPEN Emerging role of tumor cell plasticity in modifying therapeutic response Siyuan Qin1, Jingwen Jiang1,YiLu 2,3, Edouard C. Nice4, Canhua Huang1,5, Jian Zhang2,3 and Weifeng He6,7 Resistance to cancer therapy is a major barrier to cancer management. Conventional views have proposed that acquisition of resistance may result from genetic mutations. However, accumulating evidence implicates a key role of non-mutational resistance mechanisms underlying drug tolerance, the latter of which is the focus that will be discussed here. Such non-mutational processes are largely driven by tumor cell plasticity, which renders tumor cells insusceptible to the drug-targeted pathway, thereby facilitating the tumor cell survival and growth. The concept of tumor cell plasticity highlights the significance of re-activation of developmental programs that are closely correlated with epithelial–mesenchymal transition, acquisition properties of cancer stem cells, and trans- differentiation potential during drug exposure. From observations in various cancers, this concept provides an opportunity for investigating the nature of anticancer drug resistance. Over the years, our understanding of the emerging role of phenotype switching in modifying therapeutic response has considerably increased. This expanded knowledge of tumor cell plasticity contributes to developing novel therapeutic strategies or combination therapy regimens using available anticancer drugs, which are likely to